Literature DB >> 9166281

Interleukin-10 is a mesangial cell growth factor in vitro and in vivo.

S J Chadban1, G H Tesch, R Foti, R C Atkins, D J Nikolic-Paterson.   

Abstract

Macrophages are involved in the pathogenesis of mesangioproliferative glomerulonephritis. As macrophages are known to produce interleukin-10 (IL-10), we investigated the effect of recombinant murine IL-10 (rIL-10) on mesangial cell growth. In vitro studies were performed using the rat 1097 mesangial cell line. These cells exhibited a dose-dependent proliferative response to rIL-10 (23% to 70% increases at 80 ng/mL; p < 0.01), as assessed by both 3H-thymidine uptake and cell count. This effect was inhibited by preincubation of rIL-10 with a neutralizing anti-IL-10 antibody. When added to cultures of growth-arrested 1097 cells, IL-10 induced dose-dependent proliferation that paralleled the effects of platelet-derived growth factor. Incubation with a neutralizing anti-IL-10 Ab for 48 hours reduced 3H-thymidine uptake (median, 27% decreases; range, 2% to 56% decreases) versus a control Ab; p < 0.05). Rat mesangial cells were also shown to express IL-10 mRNA and protein, as determined by Northern blotting and immunostaining, thereby suggesting a role for IL-10 in autocrine mesangial cell growth. To examine the effects of IL-10 in vivo, inbred male Sprague-Dawley rats were given subcutaneous rIL-10 (0.5 mg/kg) for 3 (n = 6), 7 (n = 3), or 14 days (n = 4), or vehicle control, then killed. IL-10 administration induced a transient reduction in creatinine clearance of 35% at Day 3 (p < 0.01). Following IL-10 administration, an increase in glomerular cellularity was seen, which was maximal at Day 3 (82.7 +/- 5.9 nuclei/glomerular cross section versus control 64.6 +/- 4.6, 28% increases; p < 0.001) and maintained at Day 14 (23% increases; p < 0.01). Immuno-histochemical staining for proliferating cell nuclear antigen demonstrated an increased number of proliferating cells per glomerular cross section at day 3 (48% increases versus controls; p < 0.05). Staining for alpha-smooth-muscle actin showed significant labeling only in the glomeruli of IL-10-treated animals; double-labeling with an anti-proliferating cell nuclear antigen Ab demonstrated that some of these mesangial cells were proliferating. Collectively, these results suggest that IL-10 is a growth factor for rat mesangial cells both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166281

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

1.  Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis.

Authors:  A R Kitching; M Katerelos; S J Mudge; P G Tipping; D A Power; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

Review 2.  Role of IL-10 in the progression of kidney disease.

Authors:  Inna Sinuani; Ilia Beberashvili; Zhan Averbukh; Judith Sandbank
Journal:  World J Transplant       Date:  2013-12-24

3.  Up-regulation of cytokines in glomerulonephritis associated with murine malaria infection.

Authors:  R Sinniah; L Rui-Mei; A Kara
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

4.  Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo.

Authors:  S J Chadban; G H Tesch; R Foti; H Y Lan; R C Atkins; D J Nikolic-Paterson
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

5.  Interleukin-10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea.

Authors:  Ho Jun Chin; Ki Young Na; Soo Jin Kim; Kook-Hwan Oh; Yon Su Kim; Chun Soo Lim; Suhnggwon Kim; Dong-Wan Chae
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

6.  IL-10 induces mesangial cell proliferation via a PDGF-dependent mechanism.

Authors:  T E Robertson; D J Nikolic-Paterson; L A Hurst; R C Atkins; S J Chadban
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

Review 7.  Bench-to-bedside review: Ventilation-induced renal injury through systemic mediator release--just theory or a causal relationship?

Authors:  Jan Willem Kuiper; Rosanna Vaschetto; Francesco Della Corte; Frans B Plötz; A B Johan Groeneveld
Journal:  Crit Care       Date:  2011-08-16       Impact factor: 9.097

8.  Renoprotective Mechanism of Remote Ischemic Preconditioning Based on Transcriptomic Analysis in a Porcine Renal Ischemia Reperfusion Injury Model.

Authors:  Young Eun Yoon; Kyung Hwa Choi; Sook Young Kim; Young In Cho; Kwang Suk Lee; Kwang Hyun Kim; Seung Choul Yang; Woong Kyu Han
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

Review 9.  New developments in the treatment of osteoarthritis - focus on biologic agents.

Authors:  Jose Ignacio Torrero; Carlos Martínez
Journal:  Open Access Rheumatol       Date:  2015-07-22

Review 10.  The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.

Authors:  Piotr Wojdasiewicz; Łukasz A Poniatowski; Dariusz Szukiewicz
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.